PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10541912-9	1999	A beta-adrenergic blocking agent (propranolol) led to a marked increase in the amplitude of EGG and its power spectrum.	Propranolol	34-45	amyloid beta precursor protein	Homo sapiens	0-6	
2835408-5	1988	In Group 3, a beta-adrenergic blocking dose of propranolol was added to the infusion of 50 ng/kg per min of epinephrine.	Propranolol	47-58	amyloid beta precursor protein	Homo sapiens	12-18	
9670518-1	1998	Propranolol, a beta-adrenergic blocking agent commonly used in the treatment of hypertension, decreases mesenteric blood flow during exercise, at rest, and in cirrhosis.	Propranolol	0-11	amyloid beta precursor protein	Homo sapiens	13-19	
1542139-2	1992	Treatment with propranolol, a beta blocker, is not recommended since it may produce be an alpha agonist with the potential for further elevated blood pressure.	Propranolol	15-26	amyloid beta precursor protein	Homo sapiens	28-34	
2590727-1	1989	A new method based on displacement electrophoresis has been developed for the determination of the total and free concentration of propranolol, a beta-adrenergic blocker drug, in plasma.	Propranolol	131-142	amyloid beta precursor protein	Homo sapiens	144-150	
2573188-3	1989	It was two decades later that propranolol, a beta blocker was shown to decrease portal pressure.	Propranolol	30-41	amyloid beta precursor protein	Homo sapiens	43-49	
2467944-4	1989	Blocking of the induction was achieved with the beta-antagonist, propranolol, but not with the alpha-antagonist phentolamine, indicating that this is a beta-adrenergic receptor-mediated phenomenon.	Propranolol	65-76	amyloid beta precursor protein	Homo sapiens	150-156	
6339104-12	1983	On the other hand, propranolol, a beta-blocking agent, is not only ineffective in suppressing coronary arterial spasm in 82% of the patients, but aggravates coronary arterial spasm in 41% of the patients.	Propranolol	19-30	amyloid beta precursor protein	Homo sapiens	32-38	
3326164-1	1987	Propranolol, a beta-adrenergic blocking agent, has been proposed previously as potentially useful in the treatment of certain otherwise treatment-unresponsive psychotic patients.	Propranolol	0-11	amyloid beta precursor protein	Homo sapiens	13-19	
6086560-7	1984	A beta-adrenergic blocking drug, propranolol (PR) was infused at .35 mg/min for 15 min in eight experiments on five ewes.	Propranolol	33-44	amyloid beta precursor protein	Homo sapiens	0-6	
6089015-5	1984	A beta-adrenergic effect was antagonized by propranolol but only slightly by fluphenazine.	Propranolol	44-55	amyloid beta precursor protein	Homo sapiens	0-6	
6149064-5	1984	Propranolol, a beta antagonist, blocked the effect of (-)-isoproterenol while the alpha antagonist, phentolamine, was less effective.	Propranolol	0-11	amyloid beta precursor protein	Homo sapiens	13-19	
3666269-2	1987	This was done in order to verify the hypothesis that an increase in T3 levels could result from adrenergic stimulation, since propranolol, a beta blocking agent, has proved to decrease T3 levels in man.	Propranolol	126-137	amyloid beta precursor protein	Homo sapiens	139-145	
3686434-0	1987	[Age-related changes of the systolic and diastolic function of the left ventricle under the action of a beta adrenergic blocker, anaprilin].	Propranolol	129-138	amyloid beta precursor protein	Homo sapiens	102-108	
6345501-2	1983	Propranolol, a beta-adrenergic blocking agent, has been reported as effective, in uncontrolled trials, in ameliorating symptoms of tic disorder, tardive dyskinesia, and drug-induced extrapyramidal syndrome.	Propranolol	0-11	amyloid beta precursor protein	Homo sapiens	13-19	
7424571-7	1980	The symptomatic effect of a beta-blocking agent combined with a permanent pacemaker is considered to be due to the reduced inotropic and chronotropic effect of propranolol during exercise as well as the elimination of a bradycardia-induced angina at rest.	Propranolol	160-171	amyloid beta precursor protein	Homo sapiens	26-32	
7082068-5	1982	It continues to be true at this institution that propranolol, a beta-adrenergic blocking agent, effectively neutralizes the symptoms of autonomic hyperactivity, including sweating, tremor, fever, dilation of blood vessels, and increased pulse rate without significantly affecting thyroid function.	Propranolol	49-60	amyloid beta precursor protein	Homo sapiens	62-68	
6114116-4	1981	Propranolol, a beta-adrenergic antagonist that acts competitively by blocking the adenylate cyclase receptor on efferent cells, is well recognized to cause increased airways resistance in some asthmatic and normal subjects.	Propranolol	0-11	amyloid beta precursor protein	Homo sapiens	13-19	
431848-1	1979	The possible mechanism and the therapeutic activity of a beta-blocking drug (propranolol) in 50 patients with slight "hyperthyroidism" or "dysthyroidism" are examined.	Propranolol	77-88	amyloid beta precursor protein	Homo sapiens	55-61	
7412730-0	1980	[Changes in the radiorenography curve in hypertensive patients under the influence of a beta adrenergic antagonist (propranolol)].	Propranolol	116-127	amyloid beta precursor protein	Homo sapiens	86-92	
573555-1	1979	Propranolol, a beta-adrenergic blocking agent, has found an important position in the practice of medicine.	Propranolol	0-11	amyloid beta precursor protein	Homo sapiens	13-19	
556882-4	1977	When intravenous phentolamine (an alpha-adrenergic blocking agent) or intravenous propranolol (a beta-adrenergic blocking agent) were administered for 1 hour, there was no significant change in serum prolactin levels.	Propranolol	82-93	amyloid beta precursor protein	Homo sapiens	95-101	
208799-5	1978	Epinephrine antagonizes the lipolysis induced by theophyline on the subscutaneous adipocytes, this action is increased by propranolol (a beta-adrenergic blocking agent).	Propranolol	122-133	amyloid beta precursor protein	Homo sapiens	135-141	
1160721-11	1975	Propranolol, a beta-adrenergic blocking agent, appears to reduce the tremor in at least some patients who need treatment.	Propranolol	0-11	amyloid beta precursor protein	Homo sapiens	13-19	
5097078-0	1971	Effects of propranolol (a beta adrenergic blocking agent) on some central nervous system parameters.	Propranolol	11-22	amyloid beta precursor protein	Homo sapiens	24-30	
1092284-1	1975	It has been suggested that depression is a disease of cholinergic dominance and since the beta-adrenergic blocking drug propranolol hydrochloride can cause depression, there arises the possibility that a beta-adrenergic stimulant could benefit the condition.	Propranolol	120-145	amyloid beta precursor protein	Homo sapiens	202-208	
4825234-3	1974	Concomitant infusion of propranolol (80 mug/min), a beta adrenergic antagonist, prevented the effects of isoproterenol, although propranolol itself had no effect on basal glucagon secretion.	Propranolol	24-35	amyloid beta precursor protein	Homo sapiens	50-56	
5040261-0	1972	Immediate haemodynamic effects of a beta adrenergic blocking agent-propranolol-in mitral stenosis at fixed heart rates.	Propranolol	67-78	amyloid beta precursor protein	Homo sapiens	34-40	
4928263-2	1971	The intravenous infusion of propranolol, a beta adrenergic-blocking agent, caused a rise in plasma HGH, a transient decrease in blood FFA, and no significant change in plasma insulin.	Propranolol	28-39	amyloid beta precursor protein	Homo sapiens	41-47	
4928263-9	1971	On the contrary, a beta adrenergic stimulant, isoproterenol, raised plasma insulin and blood FFA, and abolished the plasma HGH response to propranolol.	Propranolol	139-150	amyloid beta precursor protein	Homo sapiens	17-23	
22414705-5	2012	AX-CPT performance was assessed following administration of a single dose of propranolol (a beta adrenergic antagonist) and following placebo (sugar pill) administration.	Propranolol	77-88	amyloid beta precursor protein	Homo sapiens	90-96	
26762378-2	2016	Propranolol, a beta-adrenergic antagonist with anxiolytic effects, has been shown to improve verbal fluency and working memory in adults and adolescents with ASD in single-dose challenges.	Propranolol	0-11	amyloid beta precursor protein	Homo sapiens	13-19	
27747797-2	2016	Propranolol, a beta-adrenergic blocker mainly indicated for hypertension, has proven effective in treating these types of tumors.	Propranolol	0-11	amyloid beta precursor protein	Homo sapiens	13-19	
20502989-2	2010	Propranolol, a beta-adrenergic antagonist, has revealed benefit during performance of tasks involving flexibility of access to networks, a benefit also seen in ASD.	Propranolol	0-11	amyloid beta precursor protein	Homo sapiens	13-19